|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/clinical-trials-in-oncology/
课程评论：没有评论
课程名称：肿瘤学临床试验 课程概述： 本课程《肿瘤学临床试验：设计、执行与监管途径》专为临床研究专业人士、肿瘤科医生和监管专家而设，旨在深入了解肿瘤试验中的独特挑战和方法论。课程内容全面，重点介绍肿瘤临床试验中所需的特殊设计和执行策略，强调创新方法、安全管理和精准医学的整合。 课程开始时，将探讨针对肿瘤的特定试验设计，包括阶段0试验、队列扩展研究以及自适应设计，如篮子试验和伞形试验。这些设计允许同时研究多种癌症类型或治疗靶点，提供早期疗效信号，并根据患者反应迅速调整。参与者将获得关于这些先进试验方法的伦理考虑和监管要求的深刻见解。 课程尤其重视生物标志物和精准医学在肿瘤学中的作用。参与者将学习如何选择和验证预测性、预后性和药效学生物标志物，并将其纳入试验设计，以提高治疗效果。课程还涵盖伴随诊断，强调其开发及在靶向治疗中使用时的监管考量。 在肿瘤试验中，评估疗效和安全性至关重要，尤其是在处理危及生命的疾病时。课程深入探讨常见的疗效终点，如总体生存率和无进展生存期，以及在临床研究中越来越多使用的新型和替代指标。参与者还将探索在高风险患者群体中平衡疗效与安全性的复杂性，学习如何评估风险并管理不良事件。 毒性管理是课程的重要组成部分，因为肿瘤治疗通常伴有显著的副作用。课程将详细介绍与化疗、免疫疗法和靶向治疗相关的毒性管理策略，包括预防措施、支持性护理以及剂量调整和治疗中断的协议。 最后，课程将介绍新肿瘤治疗的监管审批途径，包括FDA加速疗法认定和加速审批等快速通道的概述。参与者将了解上市后监测和持续安全监测的要求，以及在肿瘤试验中知情同意的伦理挑战。 通过本课程的学习，参与者将能够设计、执行并驾驭肿瘤临床试验的监管环境，最终为创新癌症疗法的发展做出贡献。
This course, "Clinical Trials in Oncology: Design, Execution, and Regulatory Pathways," is tailored for clinical research professionals, oncologists, and regulatory specialists who are looking to deepen their understanding of the unique challenges and methodologies in oncology trials. The course is structured to provide a comprehensive overview of the specialized designs and execution strategies required in oncology clinical trials, emphasizing innovative approaches, safety management, and the integration of precision medicine.The course begins by exploring specific trial designs tailored to oncology, including phase 0 trials, cohort expansion studies, and adaptive designs like basket and umbrella trials. These designs allow for the study of multiple cancer types or treatment targets simultaneously, providing early efficacy signals and enabling rapid adjustments based on patient responses. Participants will gain insights into the ethical considerations and regulatory requirements of these advanced trial methodologies.A significant focus is placed on the role of biomarkers and precision medicine in oncology. Participants will learn how to select and validate predictive, prognostic, and pharmacodynamic biomarkers, and how to incorporate them into trial designs to enhance treatment effectiveness. The course also covers companion diagnostics, highlighting their development and regulatory considerations when used alongside targeted therapies.Evaluating efficacy and safety is crucial in oncology trials, particularly when dealing with life-threatening diseases. The course delves into common efficacy endpoints such as overall survival and progression-free survival, along with novel and surrogate markers that are increasingly used in clinical research. Participants will also explore the complexities of balancing efficacy with safety, learning to assess risks and manage adverse events in high-risk patient populations.Management of toxicities is a key component of the course, as oncology treatments often involve significant side effects. Strategies for managing toxicities associated with chemotherapy, immunotherapy, and targeted therapies are covered in detail, including prophylactic measures, supportive care, and protocols for dose adjustments and treatment discontinuation.Finally, the course addresses the regulatory pathways for the approval of new oncology treatments, including an overview of expedited programs such as the FDA's Breakthrough Therapy Designation and Accelerated Approval. Participants will understand the requirements for post-marketing surveillance and ongoing safety monitoring, as well as the ethical challenges associated with informed consent in oncology trials.By the end of this course, participants will be equipped to design, execute, and navigate the regulatory landscape of oncology clinical trials, ultimately contributing to the development of innovative cancer therapies.
